Simtra BioPharma Solutions, a contract development and manufacturing (CDMO) specializing in injectable medicines, announced the purchase from Cook Group of a 65-acre property with more than 300,000 square feet of available space for expansion under-roof near its existing manufacturing facility in Bloomington, Indiana.
Simtra is evaluating a project to design and install manufacturing lines at the site, including the company’s first U.S.-based commercial-scale capacity for oncology-focused injectable drug products. The facility would run isolator-based vial and prefilled syringe filling lines. Simtra’s model allows for “build-to-suit” solutions that meet the unique needs of individual customers and their products.
This purchase complements other previously announced investments in the company’s growth, including the $250 million construction project currently underway at Simtra’s existing Bloomington manufacturing site, and the recently completed $100+ million new production building and $14 million conjugation and purification suite being built in Halle/Westfalen, Germany.
Simtra will be working closely with Monroe County, Indiana officials on a phased development plan, and the Company will share additional details in the coming weeks.